Bellicum Pharmaceuticals Competitors and Similar CompaniesClear all
Bellicum Pharmaceuticals's competitors and similar companies include Celyad and Allogene Therapeutics.
 Bellicum Pharmaceuticals Bellicum Pharmaceuticals is a biopharmaceutical company focused on discovering and developing cellular immunotherapies. |  Celyad Celyad is a biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology. |  Allogene Therapeutics Allogene Therapeutics is a clinical-stage biotechnology company developing allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer. | |
Founding Date | Founding Date 2004 | Founding Date 2007 | Founding Date 2018 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Houston, US HQ Houston, US Houston, US South San Francisco, US | Locations Mont-Saint-Guibert, BE HQ New York, US | Locations South San Francisco, US HQ |
Employees | Employees 1386% increase | Employees 17 | Employees 2263% decrease |
Valuation ($) | Valuation ($) 778.3 k | Valuation ($) 11.8 m | Valuation ($) 585.5 m |
Financial | |||
Revenue (est.) | Revenue (est.) $1.5m (FY, 2022) | Revenue (est.) €21k (FY, 2025) | Revenue (est.) N/A |
Net income | Net income ($25m) (FY, 2022) | Net income €830k (FY, 2025) | Net income ($190.9m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Celyad
HQ
Mont-Saint-Guibert, BE
Employees
17
Celyad is a biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology.
View companyAllogene Therapeutics
HQ
South San Francisco, US
Employees
226↓ 3% decrease
Allogene Therapeutics is a clinical-stage biotechnology company developing allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer.
View company